ASCVD Risk Refinement With NT-proBNP for Statin Allocation Among Low- and Intermediate-Risk Individuals

Circulation. 2024 Dec 17;150(25):2070-2072. doi: 10.1161/CIRCULATIONAHA.124.071071. Epub 2024 Dec 16.
No abstract available

Keywords: N-terminal pro-B-type natriuretic peptide; atherosclerotic cardiovascular disease; epidemiology; population-based; primary prevention; randomized clinical trial; statin.

Publication types

  • Letter